AIClimate & EnergyFood & AgricultureHealthcareFintechHardware & SemiconductorsLogistics & Supply ChainRobotics & Automation
E12 Ventures is an early-stage venture capital firm formed through a joint venture between Mitsui & Co. Global Investment (MGI) and Morado Ventures. It manages E12 Fund I, a $105 million fund investing in startups tackling challenges across global industries including Climate Tech, AgTech, Digital Health, AI, and advanced hardware/software.
50% of their portfolio is in Healthcare. Their most common stage is series-a (62% of deals). Average disclosed round size is $14.2M (across 7 rounds with reported amounts).
Portfolio
6
Fund Size
$105M
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Neura Health | Series A | $11.4M | Sep 2025 |
 Neura | Series A | $11.4M | Sep 2025 |
| EEllipsis Health, Inc. | Series A | $45M | Jun 2025 |
 First Resonance | Unknown | — | Dec 2024 |
 Neura Health | Seed | $8M | Jan 2023 |
| Neura Health | Seed | $2.2M | Jan 2022 |
 Ciba Health | Series A | $10M | — |
| Neura Health | Series A | $11.4M | — |
Top Co-Investors
Koch Disruptive Technologies4 shared
Correlation Ventures4 shared
Pear VC4 shared
Norwest Venture Partners4 shared
Esplanade Ventures3 shared
Plug and Play Tech Center2 shared
Salesforce Ventures1 shared
CVS Health1 shared
AME Cloud Ventures1 shared
Khosla Ventures1 shared
Fortitude Ventures1 shared
Peterson Ventures1 shared
Third Prime1 shared
Craft Ventures1 shared
Blue Earth Capital1 shared
DigiTx Partners1 shared
Next Play Ventures1 shared
Qualcomm Ventures1 shared
Last updated: 20 October 2026